Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The nominations had previously been withdrawn, but FDA elected to evaluate both forms on its own initiative
Whats next for Novo Nordisk
High and strong
As an investigational medicine, its full safety profile will only become clearer through larger Phase 3 trials and, if approved, post-marketing surveillance
As a result, the FDA granted an additional indication for Wegovy to reduce the risk of major cardiovascular events in March 2024
Now accepting new patients
.png)
US$ 27.06
US$ 21.58
US$ 27.67
US$ 27.52
